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*Editor*

During the coronavirus 2019 (COVID‐19) pandemic, non‐urgent surgical procedures were discontinued to reduce the risk of COVID‐19‐related perioperative complications and help redirect scarce healthcare resources to frontline medical care[^1^](#bjs11981-bib-0001){ref-type="ref"}, [^2^](#bjs11981-bib-0002){ref-type="ref"}, [^3^](#bjs11981-bib-0003){ref-type="ref"}. However, oncology patients continue to need surgical treatment in spite of these additional risks and resource limitations[^3^](#bjs11981-bib-0003){ref-type="ref"}, [^4^](#bjs11981-bib-0004){ref-type="ref"}. This letter describes the development of a surgical oncology hub within a major epicentre of the pandemic.

The surgical oncology hub comprised of three regional network referral systems that managed tertiary referrals within Greater London, United Kingdom. Each referral network system had a "hub and spoke" organisational design. The anchor site (hub) acted as an independent tertiary referral centre, which received referrals directly from its surrounding regional referral network hospitals (spokes). Patients with the highest risk disease and greatest clinical need for surgery from the following specialties were referred to these hubs: hepato‐pancreato‐biliary; brain; breast; lung; renal; urology; dermatology; gastrointestinal; gynaecology; sarcoma; and head and neck surgery (*Fig*. [*1*](#bjs11981-fig-0001){ref-type="fig"}).
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Within each anchor site, several structural reforms were implemented to reduce the risk of nosocomial virus transmission. Clinical and administrative staff were provided with remote access to electronic records, outpatient clinic appointments were transitioned to telephone consultations where possible, and multidisciplinary meetings were held through web conferences. Patients were admitted into the hospital on the morning of surgery, and family members were not allowed to visit patients during their inpatient stay. Only asymptomatic patients with negative swab results for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) were admitted for surgery.

Theatre staff were provided with full protective clothing for all operative procedures, designated areas were assigned for donning and doffing, and intubation and extubation were performed with only the anaesthetist and one assistant within the operating room. Theatre schedules were reduced to allow deep cleaning between cases and additional smoke evacuation was performed in selected high‐risk surgical cases such as robotic surgery and orthopaedic surgery[^5^](#bjs11981-bib-0005){ref-type="ref"}. Patients were advised to self‐isolate for 14 days after discharge with weekly telephone call assessment until review in outpatients one month after surgery.

The surgical hub provided safe and timely operative treatment for 1,542 cancer patients between 1^st^ March 2020 and 1^st^ July 2020. There was no COVID‐19‐related mortality at 30‐days follow‐up. Several lessons can be learned from our experiences. Restructuring local hospitals and referral networks offers an opportunity for neighbouring healthcare institutions to establish "cold" hubs that streamline urgent surgical oncology treatment, and "hot" hubs with sufficient infrastructure and resources to treat high‐risk patients. Reconfiguration of regional network services must include regular input and feedback from referring teams, with clear pathways for treatment and follow‐up of patients. Healthcare services must remain flexible and dynamic to respond rapidly to emerging clinical evidence and changes in government guidelines during the evolving pandemic. Shifting clinical and administrative services from the hospital floor to remote working facilities with regular web‐based multi‐disciplinary meetings facilitated continuity of care whilst limiting hospital staff exposure. We believe that our experience will facilitate other centres worldwide to establish similar surgical oncology hubs during these unprecedented times.
